Journal Home
Search for

Volume 28, Issue 12, Pages 1341-1347 (December 2009)


View previous. 21 of 22 View next.

The Novel 2009 H1N1 Influenza Virus Pandemic: Unique Considerations for Programs in Cardiothoracic Transplantation

Lara A. Danziger-Isakov, MD, MPHaCorresponding Author Informationemail address, Shahid Husain, MD, MSb, Martha L. Mooney, MD, FACPc, Margaret M. Hannan, MD, FRCPd, ISHLT Infectious Diseases Council

Received 1 October 2009; received in revised form 2 October 2009; accepted 2 October 2009. published online 26 October 2009.

The emergence of the novel 2009 H1N1 influenza virus highlights unique aspects of transplant care that will require heightened vigilance in coming months. Recognition of the syndrome, aggressive diagnosis and early treatment should be paired with active preventative measures to stem the impact of infection in the transplant population. This special advisory addresses issues relevant to cardiothoracic transplant candidates, selection of donors, recipient management and those patients with mechanical circulatory support devices.

a Cleveland Clinic Children's Hospital, Cleveland, OH

b Toronto General Hospital, Toronto, Canada

c Sentara Norfolk Transplant Center: East Virginia Medical Center, Norfolk, VA

d Mater Misericordiae University Hospital, Dublin, Ireland

Corresponding Author InformationReprint requests: Lara A. Danziger-Isakov, MD, Department of Pediatrics, S-20, Children's Hospital, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195. Telephone: 216-636-1077. Fax: 216-636-3405

PII: S1053-2498(09)00770-0

doi:10.1016/j.healun.2009.10.001


View previous. 21 of 22 View next.